采用细胞免疫疗法的进展和多发性骨髓瘤的治疗突破
Jingjing Pu1,2, Ting Liu3, Amit Sharma1
1Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn, 53127, Bonn, NRW, Germany.
Experimental hematology & oncology
|October 29, 2024
概括
采用细胞免疫疗法 (ACT) 增强免疫细胞对抗癌症. 在CAR-T细胞疗法和细胞因子诱导杀手 (CIK) 细胞的进步显示出治疗多发性骨髓瘤的前景,尽管存在诸如细胞因子释放综合征等挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 采用细胞免疫疗法 (ACT) 利用免疫系统调节以向瘤细胞.
- 个性化治疗策略已经推进了患者免疫细胞的ex vivo扩张和再注入.
- 化学抗原受体 (CAR) -T细胞疗法和相关方法 (CAR-NK,CAR-巨细胞,CAR-γδT,CAR-NKT) 显著改善了治疗结果.
研究的目的:
- 为多发性骨髓瘤 (MM) 提供ACT发展的全面概述.
- 概述ACT从实验到MM的标准临床实践的演变.
- 探索细胞因子诱导杀伤细胞 (CIK) 治疗和在MM治疗中CAR-CIK的潜力.
主要方法:
- 对MM患者采用细胞治疗的临床前和临床研究的综述.
- 分析各种ACT模式的进展,包括基于CAR的疗法.
- 检查替代ACT方法,如CIK细胞疗法.
主要成果:
- ACT已发展成为多发性骨髓瘤的重要治疗方式.
- 卡尔-T细胞疗法及其衍生物证明了最大化的治疗结果.
- CIK和CAR-CIK疗法在MM的临床管理中显示出相当大的潜力.
结论:
- ACT,特别是CAR-T细胞疗法,代表了多发性骨髓瘤治疗的重大进展.
- 基于CIK的疗法为MM提供了一个有前途的替代或补充方法.
- 诸如细胞因子释放综合征 (CRS) 和神经毒性等挑战需要进一步的研究才能完全成功.
相关概念视频
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Bone Marrow Sampling and Transplants
304
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
304
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines
342
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
342
Cytotoxic T Cells-mediated Immune Response
853
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
853


